A
Afrânio Lineu Kritski
Researcher at Federal University of Rio de Janeiro
Publications - 216
Citations - 3852
Afrânio Lineu Kritski is an academic researcher from Federal University of Rio de Janeiro. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 30, co-authored 198 publications receiving 3376 citations. Previous affiliations of Afrânio Lineu Kritski include Universidade Federal de Minas Gerais.
Papers
More filters
Completeness of tuberculosis reporting forms in five Brazilian capitals with a high incidence of the disease* Completude das fichas de notificações de tuberculose em cinco capitais do Brasil com elevada incidência da doença
Monique Lírio,Louran Andrade,Reis Passos,Juarez Pereira Dias,Afrânio Lineu Kritski,Bernardo Galvão-Castro,Maria Fernanda Rios Grassi +6 more
TL;DR: In this paper, the authors evaluated the completeness of tuberculosis reporting forms in the greater metropolitan areas of five Brazilian capitals where the incidence of tuberculosis was high in 2010 using tabulations obtained from the Sistema Nacional de Informacao de Agravos de Notificacao (National Case Registry Database).
Works in the field of tuberculosis study published in the Brazilian Journal of Pulmonology between 2004 and 2011: types of articles, study models, level of scientific evidence, and social impact Publicações na área de tisiologia no Jornal Brasileiro de Pneumologia entre 2004 e 2011: tipos de artigos, modelos de estudo, grau de evidência científica e impacto social
TL;DR: The prospects for advances in tuberculosis (TB) research over the coming decade are paralleled only by the discoveries of Mycobacterium tuberculosis by Robert Koch in 1882, as well as by the discovery of the first effective anti-TB drug, streptomycin, by Selman Waksman in 1943.
Journal ArticleDOI
Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study.
Suely Conceição Alves da Silva,Maria Claudia Vater,Daniela Maria de Paula Ramalho,Isabela Neves de Almeida,Isabela Neves de Almeida,Silvana Spíndola de Miranda,Afrânio Lineu Kritski +6 more
TL;DR: In this paper, the authors evaluated the cost-effectiveness of Xpert®MTB/RIF (Xpert) in the diagnosis of drug-resistant tuberculosis in reference units, in scenarios with and without subsidies, and the respective cost adjustment for today.
Journal Article
Resistência aos fármacos anti-tuberculose em cepas de mycobacterium tuberculosis isoladas de pacientes atendidos em seis hospitais da região metropolitana do estado do Rio de Janeiro
Rossana Coimbra Brito,Fernanda de Carvalho Queiroz Mello,Mônica Kramer de Noronha Andrade,Haroldo José de Matos,Hedi Marinho de Melo Guedes de Oliveira,Walter Costa,Maria C.S. Lourenço,Leila de Souza Fonseca,Antonio Ruffino Netto,Afrânio Lineu Kritski +9 more
TL;DR: The occurrence of high resistance rates in hospital settings strengths the need that special attention must be given to the nosocomial TB control.
Journal ArticleDOI
Evaluation of the Commercial Kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil.
Silvana Spíndola de Miranda,Isabela Neves de Almeida,Maria Luiza Lopes,Jamilly dos Reis de Figueiredo,Lida Jouca de Assis Figueredo,Afrânio Lineu Kritski,Wânia da Silva Carvalho,Maria de Fátima Filardi Oliveira Mansur +7 more
TL;DR: The exceptional accuracy demonstrated by Kit SIRE Nitratase for isoniazid and rifampicin makes the kit an attractive option for screening M. tuberculosis strain resistance.